Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele
Authors:
- 8 June 2004
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 62 (11) , 1990-1995
Abstract
Objective: To determine whether memory loss is detectable before the symptomatic presentation of mild cognitive impairment (MCI) in those at greater genetic risk for Alzheimer disease (AD) based upon presence or absence of the e4 allele of APOE. Methods: Participants were age 50 years or older who responded to newspaper advertisements. A total of 212 cognitively normal individuals of known APOE genotype were initially enrolled in a match paradigm that included e4 homozygotes, e3/4 heterozygotes, and e4 noncarriers in a 1:1:2 ratio (53 sets). Of the original 212 individually matched participants, 180 completed at least two epochs of testing including 45 APOE e4/4 homozygotes, 42 APOE e3/4 heterozygotes, and 93 APOE e4 noncarriers, mean age 60 (±6.2) years. Of these, four developed MCI or AD during the follow-up period and were excluded from analysis. Longitudinal neuropsychological study included two verbal (Auditory Verbal Learning Test [AVLT], Selective Reminding Test [SRT]) and two visual (Complex Figure Test [CFT], Visual Retention Test) memory tests. Results: Multiple measures on both verbal memory tests showed poorer performance over a mean interval of 33 months in e4 carriers than noncarriers: AVLT total learning, long term delayed recall; SRT free and cued recall. Among those age 50 to 59 years, AVLT long term delayed recall, SRT free and cued recall, and CFT recall declined more in APOE e4 carriers. No differences were found in the domains of language, spatial skills, or executive function. Conclusions: Memory declined in APOE e4 carriers before the symptomatic presentation of MCI in a cohort whose mean age was 60 years over a median period of 33 months. The decline began prior to age 60.Keywords
This publication has 31 references indexed in Scilit:
- Longitudinal follow‐up of depressive symptoms among normal versus cognitively impaired elderlyInternational Journal of Geriatric Psychiatry, 2001
- Patterns of Brain Activation in People at Risk for Alzheimer's DiseaseNew England Journal of Medicine, 2000
- Early-Onset and Late-Onset Depression Are Independent of the Genetic Polymorphism of Apolipoprotein EDementia and Geriatric Cognitive Disorders, 1999
- Association of Angiotensin-Converting Enzyme Gene Polymorphism with Lipid Profiles in Children and Adolescents with Insulin-Dependent Diabetes mellitusHormone Research in Paediatrics, 1999
- High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary ChangesExperimental Neurology, 1998
- Neuropathology of preclinical and clinical lateonset Alzheimer's diseaseAnnals of Neurology, 1998
- Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+Biological Psychiatry, 1997
- A twin study of late-onset depression and apolipoprotein E ε4 as risk factors for alzheimer's diseaseBiological Psychiatry, 1997
- Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work groupDevelopmental Neuropsychology, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984